Does EMPAGLIFLOZIN Cause Gait inability? 41 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Gait inability have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.
41
Reports of Gait inability with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
0
Deaths
22
Hospitalizations
How Dangerous Is Gait inability From EMPAGLIFLOZIN?
Of the 41 reports, 22 (53.7%) required hospitalization, and 7 (17.1%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which EMPAGLIFLOZIN Alternatives Have Lower Gait inability Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE